Chemistry:Emylcamate

From HandWiki
Short description: Chemical compound
Emylcamate
Emylcamate.svg
Clinical data
ATC code
Legal status
Legal status
  • BR: Class C1 (Other controlled substances)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC7H15NO2
Molar mass145.202 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which would eventually replace emylcamate.

A study of the drug's effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate's 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established:

Meprobamate Emylcamate Effect
175 123 ED50 (mg/kg)
600 550 LD50 (mg/kg)
3.4 4.4 Therapeutic index

Emylcamate also has a faster intra-parenteral onset than meprobamate, 3 minutes compared with 35. [1]

References

  1. "Emylcamate, A Potent Tranquillizing Relaxant". Journal of Medicinal and Pharmaceutical Chemistry 1 (5): 443–457. 1959. doi:10.1021/jm50006a003. 

Further reading

  • "Olhando para trás: um novo caminho possível para a descoberta de drogas em psicofarmacologia." (in pt). Revista de Psiquiatria do Rio Grande do Sul 26 (2): 196–203. August 2004. doi:10.1590/S0101-81082004000200009. 

External links